Taewoong Choi is an Oncology physician affiliated with Duke University. OpenAlex indexes 73 publications with 626 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2400 Pratt St Ste 9000
Durham, NC 277053976
Telephone
919-613-5161Registry record last updated 21 Jul 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202547 payments$63,893openpaymentsdata.cms.gov ↗
- Janssen Scientific Affairs, LLCProgram year20252 payments
- Karyopharm Therapeutics Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
69.4%Thalidomide Analog58.1%Lenalidomide63%Revlimid22%Pomalyst15%Part D<11 patientsProteasome Inhibitor11.3%Ninlaro100%Part D<11 patientsMetabolism & gastrointestinal
11.7%Proton pump inhibitor6%Pantoprazole Sodium100%Part D<11 patientsSerotonin-3 Receptor Antagonist5.6%Ondansetron Hcl100%Part D≥12 patientsAnti-infectives
10.5%Fluoroquinolone Antibacterial6%Levofloxacin100%Part D≥12 patientsAzole Antifungal4.4%Fluconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms
Bone Marrow Transplantation
2026 - Barriers to Autologous Stem Cell Transplant Referral in Multiple Myeloma: Impact of Social Determinants on Referral, Evaluation, and Transplant Outcomes
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Califf, MD
Duke University
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
John Perfect, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”